πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Patent portfolio

Regeneron Ireland Designated Patents

Full USPTO pharma patent portfolio for Regeneron Ireland Designated β€” grant dates, expiration, and drug cross-links.

Patents
8,292
Expiring ≀24m
426

Quick answer

Regeneron Ireland Designated has 8,292 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 426 expire within 24 months β€” use filters for patent-cliff planning.

Page 126 of 173

  1. US 7795305

    CDDO-compounds and combination therapies thereof

    Expires Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 7795389

    Antagonizing TGF-beta activity with various ectodomains TGF-beta receptors used in combination or as fusion proteins

    Expires Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 7795295

    Small molecule inhibition of PDZ-domain interaction

    Expires Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 7795302

    Use of compositions for treating rosacea

    Expires Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 7794734

    Mannheimia haemolytica chimeric outer membrane protein PlpE and leukotoxin epitopes as a vaccine or vaccine component against shipping fever

    Expires Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 7790158

    Methods for epitope-specific and cytokine/anticytokine combination immunotherapies

    Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 7790159

    Methods, combinations and kits for treating viral infections using immunoconjugates and antibodies to aminophospholipids

    Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 7790703

    Phosphonate compounds

    Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 7790860

    Targeting and imaging tumor vasculature using conjugates that bind to aminophospholipids

    Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 7785597

    VMP-like sequences of pathogenic Borrelia

    Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 7786316

    Metalloprotein inhibitors

    Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 7786282

    Nucleic acid molecules encoding TNF-Ξ± ligand polypeptides having a CD154 domain

    Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 7786213

    Biomacromolecule polymer conjugates

    Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 7786100

    Composition and method of treating hearing loss

    Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 7786091

    Compositions and methods for ameliorating myosin VIIa defects

    Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 7781565

    Compositions and methods related to profiling a plurality of cells based on peptide binding

    Expires Mon Aug 19 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 7781397

    Human plasma hyaluronidase

    Expires Mon Aug 19 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 7781413

    SEMA3B inhibits tumor growth and induces apoptosis in cancer cells

    Expires Mon Aug 19 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 7776816

    Preserving hypoxic tissue

    Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 7776320

    Methods for therapeutic use of brain derived neurotrophic factor in the entorhinal cortex

    Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 7776361

    NELL-1 enhanced bone mineralization

    Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 7776548

    Endocytotic pathway delivery vehicle for targeting drugs and antibodies to prostate and other tissues

    Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 7776593

    Hes6 as a marker of pancreatic endocrine cells

    Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 7776827

    Method of using substance P analogs for treatment amelioration of myelodysplastic syndrome

    Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 7776908

    Wortmannin analogs and methods of using same

    Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 7777000

    Anti-viral activity of cathelicidin peptides

    Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 7776823

    Human cathelicidin antimicrobial peptides

    Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 7776537

    Method of preparing a PRRS virus vaccine

    Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 7772370

    Antifungal polypeptides

    Expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 7772192

    Compositions and methods for treatment of disease with acetylated disaccharides

    Expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 7771732

    Polymer network compositions and associated methods

    Expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 7767303

    Cleaning article containing hydrophilic polymers

    Expires Mon Jul 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7767216

    Antimicrobial compositions and methods of use

    Expires Mon Jul 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7767210

    RNA virus vaccines and methods

    Expires Mon Jul 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7763259

    Therapeutic and prophylactic vaccine for the treatment and prevention of papillomavirus infection

    Expires Mon Jul 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7763283

    Nitric oxide (NO) releasing material

    Expires Mon Jul 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7759304

    Targeting complement factor H for treatment of diseases

    Expires Mon Jul 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 7758898

    Copper lowering treatment of inflammatory and fibrotic diseases

    Expires Mon Jul 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 7759081

    Annexin proteins and autoantibodies as serum markers for cancer

    Expires Mon Jul 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 7759383

    Small molecule inhibitors of MDM2 and the uses thereof

    Expires Mon Jul 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7759338

    Soluble 1,4 benzodiazepine compounds and stable salts thereof

    Expires Mon Jul 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7754230

    Methods and related compositions for reduction of fat

    Expires Mon Jul 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 7754206

    Method for treating cancer using a Notch4 ligand antagonist

    Expires Mon Jul 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 7754872

    Liposomal phosphodiester, phophorothioate, and p-ethoxy oligonucleotides

    Expires Mon Jul 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 7749510

    Methods of eliciting or boosting a cellular immune response

    Expires Mon Jul 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 7750121

    Antibody to telomerase reverse transcriptive

    Expires Mon Jul 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 7749983

    Metabolically stable alkoxyalkyl esters of antiviral or antiproliferative phosphonates, nucleoside phosphonates and nucleoside phosphates

    Expires Mon Jul 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 7749694

    C-type lectin fold as a scaffold for massive sequence variation

    Expires Mon Jul 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Regeneron Ireland Designated have?

8,292 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Regeneron Ireland Designated patents expire?

426 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources Β· Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.